DOCSLIB.ORG

CV Zvi Laron

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
CV Zvi Laron Curriculum Vitae Professor Dr. Zvi Laron Name: Zvi Laron Born: 6 February 1927, Cernauti, Romania Academic and Professional Career since 1996 Professor (Emer.) of Pediatric Endocrinology, Sackler Faculty of Medicine, Tel Aviv University, Israel since 1993 Director, Endocrinology and Diabetes Research Unit, Schneider Children’s Medical Center of Israel (SCMCI), Petah Tikva, Israel since 1985 Head, WHO Collaborating Center for the Study of Diabetes in Youth 1983 - 1997 Incumbent of the Irene and Nicholas Marsh Chair in Endocrinology and Juvenile Diabetes, Sackler Faculty of Medicine, Tel Aviv University, Israel 1958 - 1992 Director, Institute of Pediatric and Adolescent Endocrinology, Beilinson Medical Center, Petah Tikva , Sackler Faculty of Medicine, Tel Aviv University, Israel 1956 - 1957 Research and Clinical Fellow in Pediatrics, Massachusetts, General Hospital and Harvard Medical School, Boston, USA 1952 Graduated Hadassah Hebrew University Medical School, Jerusalem, Israel Nationale Akademie der Wissenschaften Leopoldina www.leopoldina.org 1 Functions in Scientific Societies and Committees (Selection) 2005 European Group of the History of Diabetes Mellitus Founding Member since 1999 Member, Israel Ministry of Health Committee on Adolescents since 1998 Member of the National Committee for Growth Standards 1998-2000 Member of the Local Advisory Board, European Association for the Study of Diabetes (EASD) - Meeting 2000 since 1997 Member of the National Council for Child Health, Israel 1995 - 1998 Founding Member & Coordinator, Pediatric Endocrinology Mediterranean Study Group (PEMS) 1993 - 1996 President, ISPAD 1992 - 1998 Council Member, GRS 1992 Founding Member, Society of Growth Hormone Research (GRS) 1989 - 1993 Founder and First Coordinator of COPES (Coodination Office for Pediatric Endocrine Societies) 1988 - 1989 President, ESPE since 1985 Head, WHO Collaborating Center for the Study of Diabetes in Youth since 1979 President, Israel Growth and Development Association 1974 - 1979 Secretary General, ISPAD 1974 Founding Member, International Study Group of Diabetes in Children and Adolescents (ISGD) / presently ISPAD (International Society for Pediatric and Adolescent Diabetes) 1966 - 1967 President, ESPE 1961 Founding Member, European Society of Pediatric Endocrinology (ESPE) Honours and Awarded Memberships (Selection) 2011 Recipient of the Human Growth Foundation (USA) Award Nationale Akademie der Wissenschaften Leopoldina www.leopoldina.org 2 2010 Endocrine Society / Pfizer Award 2009 Israel Prize awarded by the State of Israel in recognition for contributions in the field of pediatric endocrinology and diabetes 2008 Knight, First Class of the Order of the White Rose of Finland awarded by the# President of the State of Finland 2007 Award of Honor and Merit – Israeli Society of Pediatric Endocrinology 2007 Award of Merit, Israel Endocrine Society 2001 Recipient of the Endocrine Society (USA) Clinical Investigator Award 2000 Doctor Honoris Causa, University of Medicine and Pharmacy, Timisoara, Rumania 2000 Doctor Honoris Causa, University of Novara, Italy 2000 Awarded Diploma of Distinguished Visitor of the City of Acapulco de Juarez Guerrero, Mexico 1999 Honorary Member, Dominican Society of Endocrinology and Nutrition 1999 Andrea Prader Prize – ESPE (European Society of Pediatric Endocrinology) 1998 Doctor Honoris Causa conferred by the University of Medicine and Pharmacy “Iuliu Hatieganu”, Cluj-Napoca, Romania 1998 Honorary Member of the Slovenian Pediatric Society 1998 Natan Neimann Medal, Faculty of Medicine, University of Nancy, France 1998 Centennial Medal, Italian Pediatric Society 1996 Honorary Member, Hungarian Pediatric Society 1995 Honorary Member of the Medical and Scientific Academy of Romania 1993 Award of Merit conferred by ISPAD (International Society for Pediatric and Adolescent Diabetology) 1993 Award of Merit conferred by the Korean Pediatric Society 1993 Honorary Citizenship and Medal, City of Montpellier, France 1988 Member, Elected Member, German National Academy of Sciences Leopoldina 1982 Paul Langerhans Medal and Memorial Lecture, German Diabetes Association Nationale Akademie der Wissenschaften Leopoldina www.leopoldina.org 3.
Load more

Recommended publications
  • Israel Endocrine Society
    Israel Endocrine Society Israel Endocrine Society Conference Browse the program for the upcoming event By Session All Sessions By ID 4 By Day Tuesday By Author Aizic, A. - 31 Now Viewing: All Sessions Note: The presenter's name is in bold Registration Tuesday Morning Date: Tuesday, April 9, 2013 Time: 7:30 AM - 8:00 AM Location: Oral Presentations I: Diabetes, Obesity and Metabolism Date: Tuesday, April 9, 2013 Time: 8:00 AM - 10:00 AM Location: Bareket Hall Session Chair: Benjamin Glaser Session Chair: Hannah Kanety 8:00 AM - AMPK corrects ER morphology and function in stressed pancreatic beta-cells via regulation of the ER resident protein DRP1 (ID: 25) Jakob Wikstrom (Israel) Tal Israeli (Israel) Etty Bachar-Wikstrom (Israel) Yafa Ariav (Israel) Erol Cerasi (Israel) Gil Leibowitz (Israel) 8:15 AM - Paradox In Metabolic Homeostasis: AHNAK Knockout Mice Are Resistant To Diet-Induced Obesity And Yet They Display Reduced Insulin Sensitivity (ID: 47) Maya Ramdas (Israel) Chava Harel (Israel) Natalia Krits (Israel) http://www.xcdsystem.com/ies2013/Program/index.cfm[05/04/2013 11:15:55] Israel Endocrine Society Michal Armoni, Rambam Medical Center (Israel) Eddy Karnieli, Institute of Endocrinology, Metabolism and Diabetes (Israel) 8:30 AM - Neonatal Wolfram syndrome: novel De-novo dominant mutation presenting as an unusual clinical phenotype (ID: 52) Abdulsalam Abu-Libdeh, Hadassah Hebrew University Hospital (Israel) 8:45 AM - Importance of maintaining redox potential balance in the development of type 2 diabetes (ID: 61) Tovit Rosenzweig,
    [Show full text]
  • Laron Syndrome
    European Journal of Endocrinology (2004) 151 103–106 ISSN 0804-4643 CLINICAL STUDY Diabetic retinopathy in two patients with congenital IGF-I deficiency (Laron syndrome) Zvi Laron and Dov Weinberger1 Endocrinology and Diabetes Research Unit, Schneider Children’s Medical Center, Petah Tikva, WHO Collaborating Center for the Study of Diabetes in Youth and 1Department of Ophthalmology, Rabin Medical Center, Beilinson Campus, Petah Tikva and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel (Correspondence should be addressed to Zvi Laron, Endocrinology and Diabetes Research Unit, Schneider Children’s Medical Center of Israel, 14 Kaplan Street, Petah Tikva 49202, Israel; Email: [email protected]) Abstract Objective: Animal and clinical studies have shown that excessive amounts of growth hormone or insu- lin-like growth factor-I (IGF-I) promote the development of diabetes and diabetic retinopathy. Forth- with, we present two patients with congenital IGF-I deficiency who developed type II diabetes and subsequently retinopathy. Methods: Eighteen adult patients with classical Laron syndrome (8 males, 10 females, aged 20–62 years) were followed by us since childhood or underwent fundus photography with a Nikon NF 505 instrument. Three had been treated in childhood with IGF-I, the rest were never treated, includ- ing the two patients reported. Results: Two never-treated patients were diagnosed with type II diabetes (DM) at ages 39 and 41 respectively. There was no diabetes in the families. Oral treatment was followed by insulin injections. Metabolic control was not optimal and one patient developed proliferative diabetic retinopathy, neces- sitating laser surgery. He also has nephropathy and severe neuropathy.
    [Show full text]
  • TAU Review 2009.Pdf
    Summer 2009 Faculty Altruism Turkish-Israeli Relations Mathematical Superstars TEL AVIV UNIVERSITY REVIEW A dose of Drug Development ptimism Pipeline Leads through TAU Cover Story: Doing the Math 16 Students of TAU's Gifted Program for A Dose Youth in Mathematics and Computer Science are reaping the top prizes at of Optimism 2 international competitions. With 20 different projects for drugs and medical devices coming down the pipeline, TAU researchers are playing a What Keeps major role in the development of remedies for devastating Turkish-Israeli diseases. Relations Going? 18 TAU Middle East expert Prof. Ofra Beyond the Bengio believes that Call of Duty 12 the current The Dalai Lama presents an coolness TEL AVIV UNIVERSITY REVIEW international humanitarian award Summer 2009 between the two countries will not to Dr. Galia Sabar, one of the many permanently damage relations. TAU faculty members who volunteer Issued by the Marketing and Donor Relations Dept. their time and skills to people who Development and Public Affairs Division need them. Tel Aviv University That Sinking Ramat Aviv 69978 Tel Aviv, Israel Feeling 21 A TAU researcher and Nato team Tel: +972 3 6408249 develop a way to predict sinkholes in Fax: + 972 3 6407080 the Dead Sea area. E-mail: [email protected] www.tau.ac.il Editorial staff for TAU Review and Insider Editor: Louise Shalev Contributors: Rava Eleasari, Talma Agron, Pauline Reich, Ruti Ziv, Michal Alexander, Karin Kloosterman, Carl Hoffman, Gil Zohar, Esther Singer Graphic Design: TAU Graphics Design Studio/
    [Show full text]
  • Pediatric Endocrinology
    Books & journals books Adrenal: Fluck, C. E. (ed.) & Miler, W. L. (ed.) . Disorders of the human adrenal cortex. Basel: Karger; 2018. Krieger, D. T. Cushing's syndrome. Berlin: Springer; 1982. Lajic, Svetlana . Molecular analysis of mutated P450c21 in congenital adrenal hyperplasia. Stockholm: Department of Women and Child Health Pediatr; 1998. Lehnert, Hendrik (ed.) . Pheochromocytoma; pathophysiology and clinical management. Basel: Karger; 2004. New, Maria . Advances in steroid disorders in children. Parma: Universita' Degli Studi di Parma; 2000. New, Maria I. (ed.) & Levine, Lenore S. (ed.) . Adrenal diseases in childhood. Basel: Karger; 1984. Vinson, G. P. (ed.) & Anderson, D. C. (ed.) . Adrenal glands, vascular system and hypertension. Bristol: Journal of Endocrinology; 1996. Aging: Brunner,D Jokl, E Eds. Physical activity and aging Basel: Karger,S; 1970. Corpas, Emiliano (ed.) . Endocrinology of Aging ; clinical aspects in diagrams and images. Amsterdam: Elsevier; 2021. Morrison, Mary F. (ed.) . Hormones, gender and the aging brain ; the endocrine basis of geriatric psychiatry. Cambridge: Cambridge University Press; 2000. Olshansky, S. Jay & Carnes, Bruce A. The Quest for immortality ; science at the frontiers of aging. New York: W. W. Norton & Company; 2001. Sinnott, Jan D. Sex roles and Aging : theory and research from a systems perspective. Basel: Karger; 1986. Werner Kohler, Jena (ed.) . Altern und lebenszeit ; vortrage anlablich der jahresversammlung vom 26. bis 29. ; marz 1999 zu halle (saale). Halle: Deutsche Akademie der Naurforscher Leopoldin; 1999. Auto-Immunity: Altman, Amnon (ed.) . Signal transducation pathways in autoimmunity. Basel: Karger; 2002. Bastenie, P. A. (ed.) & Gept, W. (ed.) & Addison, G. M. (ed.) . Immunity and autoimmunity in diabetes mellitus ; proceedings of the francqui foundation colloquium, ; brussels, april 30- may 1, 1973.
    [Show full text]
  • ISGD to ISPAD: 30 Years
    ISGD to ISPAD: 45 years 1974 – 2019 Prepared by Stu Brink, ISPAD Historian BRINK 1 12 June 1974: “Chateau Lestradet” Paris Jacques Besse, Rene Francois, Roger Jean, Henri Lestradet, Paul Maestraggi, Claude de Menibus, Philippe Tric: France Alina Margolis, Poland Giuseppe Chiumello: Italy Zvi Laron: Israel Helmuth Jean Loeb: Belgium Leo Matajc: Yugoslavia Albert Megevand: Switzerland Enric Vicens-Calvet: Spain Madeline Von Wolff: Switzerland Bruno Weber: West Germany BRINK 2 Prior to 1974: Genesis Pediatric diabetology mostly ignored by pediatric endocrinology Most pediatric diabetes patients receive care by adult diabetologists around the world IDF, ADA, BDA, EASD with very little focus on pediatric or adolescent diabetes issues BRINK 3 1975 Henri Lestradet, Hopital des Enfants-Malades, Paris, France: First President of ISGD BRINK 4 1975 Zvi Laron: Beilinson Center, Tel Aviv University, Petah Tikva, Israel: First Secretary- General of ISGD Fifth President of ISGD/ISPAD BRINK 5 1975 Helmuth Jean Loeb, Hopital Universitaire Saint Pierre, Bruxelles, Belgique: First Treasurer of ISGD BRINK 6 1974 ISGD created with members from Belgium, France, Israel, Italy, Poland, Spain, Switzerland, West Germany, Yugoslavia First meeting at “Chateau Lestradet” after rejection of pediatric subsection by IDF Initial constitution and working by-laws created with provision for Steering Committee officers and Advisory Council BRINK 7 1975: ISGD Year 2 Expansion From USA: Arlan Rosenbloom, Robert Kaye, Robert Jackson, Richard Guthrie, Donnell Etzwiler,
    [Show full text]
  • ESPE Newsletter Farewell News from the from Franco Secretary General
    The newsletter of the ESPEESPE News Newsletter 1 bringing the latest in paediatric endocrinology to you Improving care of children with endocrine diseases by promoting knowledge and research Issue 17 • Winter 2011 ISSN 2045-5003 (online) ESPE News Contents (click on a link below) › ESPE Annual Business Meeting › Messages from Secretary General › ESPE 2011 Prizewinners ESPE has reached its › Novel Genetic Form of Childhood Hypoglycaemia Identified › ESPE Summer School 2011 first half-century! › New Accreditation & Syllabus Subcommittee › ESPE Clinical Fellowship Programme › ESPE Research Fellowship Programme The eSPe 50Th MeeTing Took Place in glasgow on › Research Fellowship Grant Recipients 25–28 September 2011. To mark this important milestone ESPE Sabbatical Leave Programme in the history of our Society, the scientific theme › ‘evidence-based Paediatric endocrinology – its Strengths › 6th Advanced Seminar in Developmental Endocrinology and limitations’ gave delegates the opportunity to look back at what we know, critically appraise the basis of that › Future Meetings knowledge (with an emphasis on pathophysiology and the evidence behind clinical practice), showcase current Welcome to issue 17 research and look to the future as eSPe becomes an increasingly international forum for the exchange of high quality basic scientific and clinical information. in ThiS iSSue, we present for the first time the To commemorate this milestone in eSPe’s history, the new eSPe logo was unveiled and new eSPe logo and the new design. We hope you members were presented with the newly designed tie or scarf and a copy of the new eSPe like the changed face of the newsletter. This issue history book ‘eSPe – The First 50 Years’ edited by Wolfgang Sippell, which tells the story of also contains notes and photographs from the 50th eSPe’s development from a small club of friends into an international scientific society.
    [Show full text]
  • Prof. Laron's Publications
    Prof. laron's publications (for digital or scaned copies, please contact the library) 30th annual meeting of the European Society for Paediatric Endocrinology (ESPE). Berlin A 25-28 1991. EFFECTS OF PHYSICAL & BIOCHEMICAL CHANGES 1ft GH DEFICIENT PATIENTS (GHD) AFTER INTERRUPTION OF hCH THERAPY AT FINAL HEIGHT AND RETREATMENT IN ADULTHOOD. Hormone Res. 1991;35(Suppl. 2):Abstract 109. – Please contact the medical library for a copy. 30th annual meeting of the European Society for Paediatric Endocrinology (ESPE). Berlin A 25-28 1991. PREDISPOSITION TO HYPERTENSION AND PERSISTENT MICROALBU- MINUR1A IN TYPE 1 DIABETIC YOUNGSTERS. Hormone Res. 1991;35(Suppl. 2):Abstract 33. – Please contact the medical library for a copy. 30th annual meeting of the European Society for Paediatric Endocrinology (ESPE). Berlin A 25-28 1991. MODULATION OF 1GF-I RECEPTORS BY hCH TREATMENT OF CONSTITUTIONALLY SHORT CHILDREN (CSS). Hormone Res. 1991;35(Suppl 2):Abstract 146. – Please contact the medical library for a copy. 30th annual meeting of the European Society for Paediatric Endocrinology (ESPE). Berlin A 25-28 1991. PROLACTIN RESPONSE TO i.v. IGF-1 AND TRH STIMULATION IN LARON TYPE DWARFISM (LTD) PATIENTS’AND CONTROLS. Hormone Res. 1991;35(Suppl. 2):Abstract 147. – Please contact the medical library for a copy. 30th annual meeting of the European Society for Paediatric Endocrinology (ESPE). Berlin A 25-28 1991. FINAL HEIGHT IN GIRLS WITH CENTRAL PRECOCIOUS PUBERTY (CPP) TREATED WITH THE Gn-RH AGONIST D-TRP-6-LHRH. Hormone Res. 1991;35(Suppl. 2):Abstract 151. – Please contact the medical library for a copy. 30th annual meeting of the European Society for Paediatric Endocrinology (ESPE).
    [Show full text]
  • Diabetic Retinopathy in Two Patients with Congenital IGF-I Deficiency (Laron Syndrome)
    European Journal of Endocrinology (2004) 151 103–106 ISSN 0804-4643 CLINICAL STUDY Diabetic retinopathy in two patients with congenital IGF-I deficiency (Laron syndrome) Zvi Laron and Dov Weinberger1 Endocrinology and Diabetes Research Unit, Schneider Children’s Medical Center, Petah Tikva, WHO Collaborating Center for the Study of Diabetes in Youth and 1Department of Ophthalmology, Rabin Medical Center, Beilinson Campus, Petah Tikva and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel (Correspondence should be addressed to Zvi Laron, Endocrinology and Diabetes Research Unit, Schneider Children’s Medical Center of Israel, 14 Kaplan Street, Petah Tikva 49202, Israel; Email: [email protected]) Abstract Objective: Animal and clinical studies have shown that excessive amounts of growth hormone or insu- lin-like growth factor-I (IGF-I) promote the development of diabetes and diabetic retinopathy. Forth- with, we present two patients with congenital IGF-I deficiency who developed type II diabetes and subsequently retinopathy. Methods: Eighteen adult patients with classical Laron syndrome (8 males, 10 females, aged 20–62 years) were followed by us since childhood or underwent fundus photography with a Nikon NF 505 instrument. Three had been treated in childhood with IGF-I, the rest were never treated, includ- ing the two patients reported. Results: Two never-treated patients were diagnosed with type II diabetes (DM) at ages 39 and 41 respectively. There was no diabetes in the families. Oral treatment was followed by insulin injections. Metabolic control was not optimal and one patient developed proliferative diabetic retinopathy, neces- sitating laser surgery. He also has nephropathy and severe neuropathy.
    [Show full text]
  • Issue #93-104, 1977
    ISSN 0090-135C •Of MM LIBRARY NETWORK/MEDLARS TECHNICAL BULLETIN of the Library Component of the Biomedical Communications Network JANUARY 1977 NO. 93 THE CONTENTS OF THIS PUBLICATION ARE NOT COPYRIGHTED AND MAY BE FREELY REPRODUCED TABLE OF CONTENTS Page ON-LINE TECHNICAL NOTES 2 HEAD INJURIES REVISITED JUDICIOUS USE OF STRINGSEARCH IN ON-LINE AND OFF-LINE SEARCHING ... 4 RESPIRATION: A HEDGE 6 AVLINE UPDATE 9 MEDLINE/TOXLINE TRAINEES 10 NEW SERIALS ANNOUNCEMENT - DECEMBER 1976 11 LIST OF MONOGRAPHS INDEXED - JANUARY 1977 13 LIST OF MONOGRAPHS INDEXED - FEBRUARY 1977 15 U.S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE Public Health Service National Institutes of Health Page 2 LIBRARY NETWORK/MEDLARS TECHNICAL BULLETIN TECHNICAL NOTES PLEASE QUERY THE ON-LINE NEWS FILES DAILY AT NLM FOR SPECIAL NOTICES AND MESSAGES Whenever applicable, the heading of each Technical Note will include a reference to the section/ page of the NLM On-L-ine Services Reference Manual which is considered most relevant to the item being discussed (e.g., Manual II-9). Users should keep in mind that the item may pertain to other sections of the Manual. JOURNAL CITATION DATA BASES NTIS FOREIGN DISTRIBUTION POLICY (Manual IV-11) MEDLINE and SDILINE were updated with Jan- The National Technical Information Service, uary 77 citations on December 20th. The sizes, which distributes MEDLARS tools and other tech- Index Medians date ranges and entry dates are nical reports, has announced a new policy given below: affecting orders from the United Kingdom, France, MEDLINE (Jan75 - Jan 77) 571,622 Belgium, Switzerland, and Japan. Orders origin- (Entry dates 741205 to 761203) ating in these countries must now be sent to SDILINE (January 77) 21,626 the managing dealers listed below, rather than (Entry dates 761121 to 761203) to NTIS.
    [Show full text]
  • Laron Syndrome - from Man to Mouse Zvi Laron • John J
    Laron Syndrome - From Man To Mouse Zvi Laron • John J. Kopchick (Editors) Laron Syndrome - From Man to Mouse Lessons from Clinical and Experimental Experience Editors Zvi Laron, MD John J. Kopchick, PhD Schneider Children’s Medical Center of Israel, Edison Biotechnology Institute and Endocrine Research Unit, Department of Biomedical Sciences, Kaplan Street 14, Ohio University, 49202 Petah Tikva, 1 Water Tower Drive, The Ridges, Sackler Faculty of Medicine, Athens, OH 45701, Tel Aviv University, USA Israel e-mail: [email protected] e-mail: [email protected] ISBN: 978-3-642-11182-2 e-ISBN: 978-3-642-11183-9 DOI: 10.1007/978-3-642-11183-9 Springer Heidelberg Dordrecht London New York Library of Congress Control Number: 2010937974 © Springer-Verlag Berlin Heidelberg 2011 This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilm or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permitted only under the provisions of the German Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Springer. Violations are liable to prosecution under the German Copyright Law. The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. Product liability: The publishers cannot guarantee the accuracy of any information about dosage and appli- cation contained in this book.
    [Show full text]
  • Diabetes211209.Pdf
    ÒÂÈΉ†˙ÈÎÂ˙ DAY 1: Monday December 21, 2009 – Evening ¨È‡ÂÙ¯†˙ˆ†È˘‡Ï†„ÚÂÈÓ†ÒΉ Æ˙¯ÎÂÒφÌÈ¯Â˘˜‰†ÌÈÓÂÁ˙‰†Ô‚ӆÏÎӆȇÂÙ¯≠‡¯Ù†ȄÂÚÈÒ OPENING CEREMONY 7:00 PM Welcome and Introduction to Laniado Hospital Mr Chaim Hammerman ÌȉӉ†Ìȇ˘Â†Ì‚¯˙·†„˜Ó˙ȆÒΉ CEO of Laniado Hospital ÆÈÈϘ†ÈÏÂÙȈڄÈφ˙¯ÎÂÒ‰†ÌÂÁ˙·†Ìȯ˜ÁÓ·†˙ÈÁ‰†„ÂÁ†˙‡ Dr Avinoam Shkolnik, Medical Director Laniado Hospital Æ˙¯ÎÂÒ·†ÈÏÏÂΉ†ÏÂÙÈˉ†Í¯ÚӆωȆԂ¯‡Ï†˙ÂÒÁÈÈ˙‰†ÍÂ˙ 7:20 PM Greetings Rabbi Yaakov Litzman, Deputy Minister of Health ÌÈÏÈ·ÂÓ†ÌȇÙ¯†È„ȆÏچ¯·ÚÂȆ˙‡ˆ¯‰‰ Ms Miriam Feirberg Ikar, Mayor of Netanya ÆÌÏÂډ†ı¯‡‰Ó†˙¯ÎÂÒ‰†ÌÂÁ˙· 7:30 PM A Vision of Diabetes Care for the 2010s Æ˙‡ˆ¯‰‰†Í¯Â‡Ï†‰ÂÂÏ˙ȆÈËÏÂÓÈ҆̂¯˙ Moti Ravid, Israel Diabetes Association Itamar Raz, National Council on Diabetes Richard Hellman, American Association of Clinical Endocrinologists ∫˙ÈÓ‡ÏÈ·†˙ÈÚ„Ó†‰„Ú Prof Harold Lebovitz 8:00 PM The Bildirici Diabetes Center: Implementing the future of Diabetes Care Mark Niven Prof Martin Grajower Director of Endocrine and Diabetes Unit, Laniado Hospital, Netanya, Israel Prof Graham Hitman 8:15 PM Prevention of Type 1 Diabetes Itamar Raz Prof Derek LeRoith Professor and Head of Diabetes Unit, Department of Medicine, Hadassah University Hospital, Ein-Karem, Jerusalem, Israel; Chairman of National Council on Diabetes; President of D-Cure; Past President of Israel Diabetes Association ∫˙ÈÓ˜ӆ˙‚¯‡Ó†‰„Ú Dr Mark J NIVEN 8:45 PM The Interface of Medicine and Halacha (Jewish Law) and a tribute to Gabriel Cabra Sara Farkash R.N.
    [Show full text]
  • ISGD to ISPAD: 47 Years
    ISGD to ISPAD: 47 years 1974 – 2021 Prepared by Stu Brink, ISPAD Historian BRINK 1 12 June 1974: “Chateau Lestradet” in Paris Jacques Besse, Rene Francois, Roger Jean, Henri Lestradet, Paul Maestraggi, Claude de Menibus, Philippe Tric: France Alina Margolis, Poland Giuseppe Chiumello: Italy Zvi Laron: Israel Helmuth Jean Loeb: Belgium Leo Matajc: Yugoslavia Albert Megevand: Switzerland Enric Vicens-Calvet: Spain Madeline Von Wolff: Switzerland Bruno Weber: West Germany BRINK 2 Prior to 1974: Genesis Pediatric diabetology mostly ignored by pediatric endocrinology Most pediatric diabetes patients receive care by adult diabetologists around the world IDF, ADA, BDA, EASD with very little focus on pediatric or adolescent diabetes issues BRINK 3 1975 Henri Lestradet, Hopital des Enfants- Malades, Paris, France: First President of ISGD BRINK 4 1975 Zvi Laron: Beilinson Center, Tel Aviv University, Petah Tikva, Israel: First Secretary- General of ISGD Fifth President of ISGD/ISPAD BRINK 5 1975 Helmuth Jean Loeb, Hopital Universitaire Saint Pierre, Bruxelles, Belgique: First Treasurer of ISGD BRINK 6 1974 ISGD created with members from Belgium, France, Israel, Italy, Poland, Spain, Switzerland, West Germany, Yugoslavia First meeting at “Chateau Lestradet” after rejection of pediatric subsection by IDF Initial constitution and working by-laws created with provision for Steering Committee officers and Advisory Council BRINK 7 1975: ISGD Year 2 Expansion From USA: Arlan Rosenbloom, Robert Kaye, Robert Jackson, Richard Guthrie, Donnell Etzwiler,
    [Show full text]